OAC
ADMA icon

OMERS Administration Corp’s ADMA Biologics ADMA Stock Holding History

OMERS Administration Corp’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167K Buy
+20,000
New +$182K ﹤0.01% 867
2025
Q4 		– Sell
-45,600
Closed -$668K – 1038
2025
Q3 		$668K Buy
+45,600
New +$782K ﹤0.01% 660

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

OMERS Administration Corp's ADMA Position: Q2 2026 in Review

OMERS Administration Corp opened a new position in ADMA Biologics (ADMA) in Q2 2026: 20,000 shares worth $167K. The stake represents ﹤0.01% of the portfolio and ranks #867 among its holdings. This is a return to the name: OMERS Administration Corp previously reported a position in ADMA as recently as Q3 2025.

OMERS Administration Corp first reported a position in ADMA in Q3 2025 and has held it in 2 quarters since. The position peaked at $668K in Q3 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • OMERS Administration Corp held 20,000 shares of ADMA Biologics worth $167K as of Q2 2026.
  • ADMA Biologics was a new OMERS Administration Corp position in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #867 holding.
  • OMERS Administration Corp first reported a position in ADMA Biologics in Q3 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's ADMA Biologics position peaked at $668K in Q3 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.